SCHEMBL12590010

SCHEMBL12590010

c1ccc(-n2cnc3cc(-c4cccnc4)ccc32)nc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.56
▸ VHL P40337 1/20 0.47
▸ GABRA1 P14867 1/20 0.44
▸ GABRG2 P18507 1/20 0.44
▸ GABRB3 P28472 1/20 0.44
▸ GABRA5 P31644 1/20 0.44
▸ GABRA3 P34903 1/20 0.44
▸ GABRA2 P47869 1/20 0.44
▸ QPCT Q16769 1/20 0.44
▸ QPCTL Q9NXS2 1/20 0.44
▸ CYP17A1 P05093 3/20 0.43
▸ CYP11B1 P15538 2/20 0.43
▸ CYP11B2 P19099 2/20 0.43
▸ CYP19A1 P11511 1/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ KDR P35968 1/20 0.42
▸ CYP2A6 P11509 3/20 0.42
▸ LCK P06239 1/20 0.42
▸ PLK1 P53350 1/20 0.41
▸ PLK3 Q9H4B4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12590009 0.85 QPCT (0.47) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL6659220 0.79 CYP11B1 (0.53) VHLCYP17A1CYP11B1CYP11B2CYP19A1
SCHEMBL18999462 0.79 POLB (0.52) POLBKDRLCKFGFR1ALDH1A1
SCHEMBL16036625 0.77 POLB (0.70) POLBCYP17A1CYP1A2FGFR1ALDH1A1
SCHEMBL11988767 0.76 POLB (0.64) POLBCYP11B1CYP11B2KDRFGFR1
SCHEMBL12051554 0.76 ALOX5AP (0.47) VHLQPCTQPCTLCYP17A1CYP11B1
SCHEMBL28571576 0.75 POLB (0.66) POLBCYP17A1CYP1A2LCKFGFR1
SCHEMBL16037807 0.74 POLB (0.70) POLBCYP17A1CYP1A2FGFR1ALDH1A1
SCHEMBL3149017 0.73 AURKA (0.60) KDRLCKFGFR1
SCHEMBL7501680 0.73 MKNK2 (0.71) LCKMKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2336122-B1 1-PYRIMIDINYL- OR 1-PYRIDINYL-2-AMINO BENZIMIDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES FOR THE TREATMENT OF CANCER VERTEX PHARMA (US) 2014-05-14 — — EP disclosed
EP-2336122-A1 1-pyrimidinyl- or 1-pyridinyl-2-amino benzimidazole derivatives and related compounds as inhibitors of protein kinases for the treatment of cancer Vertex Pharmaceuticals Incorporated (US) 2011-06-22 — — EP disclosed
WO-2007015923-A2 BENZIMIDAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-02-08 — — WO disclosed
Send feedback